Brief: Black Diamond Therapeutics Presents Preclinical Data On Bdtx-1535 And Bdtx-4933

Black Diamond Therapeutics

26/10/2022 13:23

Oct 26 (Reuters) - Black Diamond Therapeutics Inc
 BDTX.O :
    * BLACK DIAMOND THERAPEUTICS PRESENTS PRECLINICAL DATA ON
BDTX-1535 AND BDTX-4933 AT 34TH EORTC-NCI-AACR SYMPOSIUM ON
MOLECULAR TARGETS AND CANCER THERAPEUTICS
    * BLACK DIAMOND THERAPEUTICS - EXPECTS TO PROVIDE A CLINICAL
UPDATE ON BDTX-1535 IN 2023

Source text for Eikon:  ID:nGNX8rHV1j 
Further company coverage:  BDTX.O 
 ((Reuters.Briefs@thomsonreuters.com))